الصفحة الرئيسية>>Signaling Pathways>> DNA Damage/DNA Repair>> CDK>>ML167

ML167 (Synonyms: CID 44968231)

رقم الكتالوجGC14162

ML167 هو مثبط كيناز 4 (Clk4) يشبه Cdc2 انتقائي للغاية مع IC50 من 136 نانومتر ،> انتقائية 10 أضعاف للكينازات وثيقة الصلة Clk1 و Clk2 و Clk3 و Dyrk1A / 1B

Products are for research use only. Not for human use. We do not sell to patients.

ML167 التركيب الكيميائي

Cas No.: 1285702-20-6

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
59٫00
متوفر
10mg
82٫00
متوفر
25mg
180٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

ML167 is a highly selective inhibitor of Cdc2-like kinase 4 (Clk4) with IC50 value of 136nM [1].

The Clk family enzymes play their roles in gene splicing via phosphorylating the major component of the spliceosome, SR proteins. Small molecule probes that target Clk’s can be used to study the modulating functions of these kinases in gene splicing. ML167 is found as the first fully selective inhibitor of Clk4 but not other related kinases including Clk1, Clk2 and Clk3 and Dyrk1A/1B. It is 10-fold more potent against Clk4 over other kinases. The treatment of ML167 on Caco-2 cells proves that ML167 is highly cell-permeable. Besides that, ML167 is also found to be an ATP-competitive inhibitor [1].

References:
[1] Rosenthal A S, Tanega C, Shen M, et al. An inhibitor of the Cdc2-like kinase 4 (Clk4). 2011.

مراجعات

Review for ML167

Average Rating: 5 ★★★★★ (Based on Reviews and 39 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for ML167

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.